Urgent.News

What's breaking now, across thousands of outlets.

Science

Possible new treatment for Wilson disease seeks to minimize effects on mitochondria using metformin

Wilson disease is a rare genetic condition in which the liver loses the ability to effectively remove copper, allowing it to accumulate in the body. This toxic buildup affects the liver, brain, eyes and kidneys and is particularly bad for mitochondria, the cell's all-important power plants.

Possible new treatment for Wilson disease seeks to minimize effects on mitochondria using metformin

A new study published in Scientific Reports suggests a potential treatment for Wilson disease that could minimize damage to mitochondria using metformin, a drug commonly used to manage type 2 diabetes. Wilson disease is a rare genetic condition where the liver cannot effectively remove excess copper, leading to toxic buildup that harms the liver, brain, eyes, and kidneys.

Current treatments focus on copper removal, but researchers at UC Davis Health are exploring the effects of metformin on mitochondrial function. Mitochondria, the cell's powerhouses, play a crucial role in energy production, and mitochondrial dysfunction is particularly problematic in Wilson disease. The researchers found that metformin improved mitochondrial bioenergetics, particularly in female mice, which exhibited more severe mitochondrial injury than their male counterparts.

Metformin's ability to bind to metal molecules, including copper, makes it an intriguing candidate for treating Wilson disease, as it is both safe and inexpensive. While the effects on human patients are still unestablished, early diagnosis and access to this therapy could potentially prevent severe symptoms and complications.

Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at medicalxpress.com →

More in Science

More from Thursday 19 November →